Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Sleep Impairment in APOEε4/ε4 Subjects at Risk of Developing Alzheimer's Disease: Risk Factor for Cognitive Decline?

NCT05649514 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05649514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05649514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Sleep Impairment in APOEε4/ε4 Subjects at Risk of Developing Alzheimer's Disease: Risk Factor for Cognitive Decline?
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Recruiting
Start date
February 5, 2025
Completion date
December 1, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive decline, neuropathology, sleep disorder